免疫原性-话题@MedSci

#免疫原性#

60篇内容 | 2589人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1393823, encodeId=86cb1393823e1, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JAMA：COVID-19 mRNA疫苗在孕妇和哺乳期妇女中的免疫原性, objectType=article, longId=211300, objectId=3b922113006f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b922113006f, replyNumber=0, likeNumber=84, createdTime=2021-05-16, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b922113006f, moduleTitle=JAMA：COVID-19 mRNA疫苗在孕妇和哺乳期妇女中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b922113006f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393822, encodeId=296c139382210, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=康泰生物灭活新冠疫苗（KCONVAC）I/II期临床试验数据显示出优异的安全性和免疫原性, objectType=article, longId=209884, objectId=8e3c20988469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e3c20988469, replyNumber=0, likeNumber=43, createdTime=2021-04-14, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e3c20988469, moduleTitle=康泰生物灭活新冠疫苗（KCONVAC）I/II期临床试验数据显示出优异的安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e3c20988469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393821, encodeId=8236139382106, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=中国科兴新冠疫苗智利Ⅲ期试验初步结果显示良好安全性和免疫原性, objectType=article, longId=209432, objectId=555220943299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=555220943299, replyNumber=0, likeNumber=0, createdTime=2021-04-05, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=555220943299, moduleTitle=中国科兴新冠疫苗智利Ⅲ期试验初步结果显示良好安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=555220943299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393820, encodeId=c90f1393820cb, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JAMA：单剂量SARS-CoV-2 mRNA疫苗在实体器官移植受者中的免疫原性, objectType=article, longId=208472, objectId=4e562084e27e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e562084e27e, replyNumber=0, likeNumber=80, createdTime=2021-03-18, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e562084e27e, moduleTitle=JAMA：单剂量SARS-CoV-2 mRNA疫苗在实体器官移植受者中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e562084e27e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393819, encodeId=b2d7139381975, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JAMA：COVID-19 Ad26.COV2.S疫苗在人类试验中的免疫原性研究, objectType=article, longId=208309, objectId=03342083098a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03342083098a, replyNumber=0, likeNumber=64, createdTime=2021-03-14, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03342083098a, moduleTitle=JAMA：COVID-19 Ad26.COV2.S疫苗在人类试验中的免疫原性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03342083098a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393818, encodeId=0e971393818fe, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=有关Nuwiq®在重度血友病A初治患者中免疫原性的NuProtect研究终局数据发表, objectType=article, longId=207549, objectId=bb8520e54947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb8520e54947, replyNumber=0, likeNumber=57, createdTime=2021-02-26, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb8520e54947, moduleTitle=有关Nuwiq®在重度血友病A初治患者中免疫原性的NuProtect研究终局数据发表, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb8520e54947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393817, encodeId=82e3139381e02, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Br J Cancer：牛白细胞提取物ICRP诱导乳腺癌细胞免疫原性细胞死亡的发生并建立长期抗肿瘤记忆, objectType=article, longId=206998, objectId=de54206998cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de54206998cc, replyNumber=0, likeNumber=72, createdTime=2021-02-10, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de54206998cc, moduleTitle=Br J Cancer：牛白细胞提取物ICRP诱导乳腺癌细胞免疫原性细胞死亡的发生并建立长期抗肿瘤记忆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de54206998cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393816, encodeId=91871393816da, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet子刊：COVID-19 DNA候选疫苗INO-4800的I期临床，在所有患者中触发免疫原性, objectType=article, longId=204904, objectId=620a20490483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=620a20490483, replyNumber=0, likeNumber=71, createdTime=2020-12-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=620a20490483, moduleTitle=Lancet子刊：COVID-19 DNA候选疫苗INO-4800的I期临床，在所有患者中触发免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=620a20490483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393815, encodeId=9b4b13938158e, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Neurology：帕金森病患者α-突触核蛋白活性免疫治疗PD01A的安全性和免疫原性:一项随机、单盲、1期试验, objectType=article, longId=203716, objectId=5c96203e1684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c96203e1684, replyNumber=0, likeNumber=84, createdTime=2020-11-26, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c96203e1684, moduleTitle=Lancet Neurology：帕金森病患者α-突触核蛋白活性免疫治疗PD01A的安全性和免疫原性:一项随机、单盲、1期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c96203e1684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393814, encodeId=172f13938148c, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=强生COVID-19疫苗JNJ-78436735在早期测试中具有“高度免疫原性”, objectType=article, longId=201253, objectId=db3920125372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db3920125372, replyNumber=0, likeNumber=52, createdTime=2020-09-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db3920125372, moduleTitle=强生COVID-19疫苗JNJ-78436735在早期测试中具有“高度免疫原性”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db3920125372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393813, encodeId=99e0139381395, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=JAMA：发表武汉生物新冠灭活疫苗1/2期试验结果，免疫原性和安全性良好, objectType=article, longId=199514, objectId=238819951432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=238819951432, replyNumber=0, likeNumber=61, createdTime=2020-08-17, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=238819951432, moduleTitle=JAMA：发表武汉生物新冠灭活疫苗1/2期试验结果，免疫原性和安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=238819951432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393812, encodeId=de3f1393812d5, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=J Infect Dis：重组泡状口炎病毒-扎伊尔埃博拉病毒包膜糖蛋白疫苗的免疫原性、异质性和安全性分析, objectType=article, longId=198099, objectId=0b2419809921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b2419809921, replyNumber=0, likeNumber=66, createdTime=2020-07-28, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b2419809921, moduleTitle=J Infect Dis：重组泡状口炎病毒-扎伊尔埃博拉病毒包膜糖蛋白疫苗的免疫原性、异质性和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b2419809921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393811, encodeId=b2f71393811b0, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet Infect Dis：百日咳减毒活疫苗BPZE1安全性及免疫原性研究, objectType=article, longId=197834, objectId=4a3819e8347e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a3819e8347e, replyNumber=0, likeNumber=53, createdTime=2020-07-22, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a3819e8347e, moduleTitle=Lancet Infect Dis：百日咳减毒活疫苗BPZE1安全性及免疫原性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a3819e8347e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393810, encodeId=9b961393810d3, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Lancet：蚊唾液疫苗耐受性及免疫原性研究, objectType=article, longId=196549, objectId=27f9196549d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27f9196549d4, replyNumber=0, likeNumber=67, createdTime=2020-06-28, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27f9196549d4, moduleTitle=Lancet：蚊唾液疫苗耐受性及免疫原性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27f9196549d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393809, encodeId=2503139380991, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=LANCET: 蚊唾液肽基疫苗的安全性和免疫原性：一项随机，安慰剂对照，双盲，1期试验, objectType=article, longId=195943, objectId=34f4195943e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34f4195943e4, replyNumber=0, likeNumber=0, createdTime=2020-06-18, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34f4195943e4, moduleTitle=LANCET: 蚊唾液肽基疫苗的安全性和免疫原性：一项随机，安慰剂对照，双盲，1期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34f4195943e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393808, encodeId=bd4f13938083a, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=IBD：大剂量流感疫苗对炎性肠病患者接受抗TNF单一疗法后的免疫原性的影响, objectType=article, longId=189576, objectId=d9961895e68e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9961895e68e, replyNumber=0, likeNumber=74, createdTime=2020-03-10, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9961895e68e, moduleTitle=IBD：大剂量流感疫苗对炎性肠病患者接受抗TNF单一疗法后的免疫原性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9961895e68e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393807, encodeId=10cc139380e0e, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Cell Death & Disease：EPHB4抑制能够激活ER应激来促进前列腺癌细胞免疫原性细胞死亡, objectType=article, longId=182747, objectId=a22e182e47a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a22e182e47a5, replyNumber=0, likeNumber=68, createdTime=2019-11-11, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a22e182e47a5, moduleTitle=Cell Death & Disease：EPHB4抑制能够激活ER应激来促进前列腺癌细胞免疫原性细胞死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a22e182e47a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393806, encodeId=9b15139380671, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=J Rheumatol：苏金单抗在银屑病关节炎和强直性脊柱炎患者中的免疫原性, objectType=article, longId=174424, objectId=74141e442434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74141e442434, replyNumber=0, likeNumber=64, createdTime=2019-06-30, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74141e442434, moduleTitle=J Rheumatol：苏金单抗在银屑病关节炎和强直性脊柱炎患者中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74141e442434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393805, encodeId=ee81139380597, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Inflam Bowel Dis：炎症性肠病患者从单抗治疗药物转换为生物仿制药CT-P13后的药物存活和免疫原性, objectType=article, longId=157182, objectId=d67915e182c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d67915e182c6, replyNumber=0, likeNumber=50, createdTime=2019-01-03, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d67915e182c6, moduleTitle=Inflam Bowel Dis：炎症性肠病患者从单抗治疗药物转换为生物仿制药CT-P13后的药物存活和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d67915e182c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1393804, encodeId=9c16139380491, content=<a href='/topic/show?id=718528982e3' target=_blank style='color:#2F92EE;'>#免疫原性#</a>, objectTitle=Semin Arthritis Rheu：依那西普浓度和免疫原性不会影响幼年特发性关节炎患者对依那西普的反应, objectType=article, longId=149187, objectId=d27d14918ef6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d27d14918ef6, replyNumber=0, likeNumber=63, createdTime=2018-09-22, rootId=0, userName=ms5353107019656438, userId=7d822500145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d27d14918ef6, moduleTitle=Semin Arthritis Rheu：依那西普浓度和免疫原性不会影响幼年特发性关节炎患者对依那西普的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d27d14918ef6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫原性

2020-05-29

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JAMA：COVID-19 mRNA疫苗在孕妇和哺乳期妇女中的免疫原性

2021-05-16

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

康泰生物灭活新冠疫苗（KCONVAC）I/II期临床试验数据显示出优异的安全性和免疫原性

2021-04-14

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

中国科兴新冠疫苗智利Ⅲ期试验初步结果显示良好安全性和免疫原性

2021-04-05

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JAMA：单剂量SARS-CoV-2 mRNA疫苗在实体器官移植受者中的免疫原性

2021-03-18

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JAMA：COVID-19 Ad26.COV2.S疫苗在人类试验中的免疫原性研究

2021-03-14

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

有关Nuwiq®在重度血友病A初治患者中免疫原性的NuProtect研究终局数据发表

2021-02-26

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Br J Cancer：牛白细胞提取物ICRP诱导乳腺癌细胞免疫原性细胞死亡的发生并建立长期抗肿瘤记忆

2021-02-10

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet子刊：COVID-19 DNA候选疫苗INO-4800的I期临床，在所有患者中触发免疫原性

2020-12-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Neurology：帕金森病患者α-突触核蛋白活性免疫治疗PD01A的安全性和免疫原性:一项随机、单盲、1期试验

2020-11-26

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

强生COVID-19疫苗JNJ-78436735在早期测试中具有“高度免疫原性”

2020-09-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

JAMA：发表武汉生物新冠灭活疫苗1/2期试验结果，免疫原性和安全性良好

2020-08-17

仁心济世 (审核中...)

前往app查看评论内容

#免疫原性#

J Infect Dis：重组泡状口炎病毒-扎伊尔埃博拉病毒包膜糖蛋白疫苗的免疫原性、异质性和安全性分析

2020-07-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet Infect Dis：百日咳减毒活疫苗BPZE1安全性及免疫原性研究

2020-07-22

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Lancet：蚊唾液疫苗耐受性及免疫原性研究

2020-06-28

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

LANCET: 蚊唾液肽基疫苗的安全性和免疫原性：一项随机，安慰剂对照，双盲，1期试验

2020-06-18

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

IBD：大剂量流感疫苗对炎性肠病患者接受抗TNF单一疗法后的免疫原性的影响

2020-03-10

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Cell Death & Disease：EPHB4抑制能够激活ER应激来促进前列腺癌细胞免疫原性细胞死亡

2019-11-11

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

J Rheumatol：苏金单抗在银屑病关节炎和强直性脊柱炎患者中的免疫原性

2019-06-30

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Inflam Bowel Dis：炎症性肠病患者从单抗治疗药物转换为生物仿制药CT-P13后的药物存活和免疫原性

2019-01-03

ms5353107019656438 (审核中...)

前往app查看评论内容

#免疫原性#

Semin Arthritis Rheu：依那西普浓度和免疫原性不会影响幼年特发性关节炎患者对依那西普的反应

2018-09-22

科室
- - 订阅+
  - 更多科室
工具
服务